Biggest News Aggregation in the World
📰 Johnr Moore News

Johnr Moore News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Johnr Moore. Real-time updates on events, politics, business and more.

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Short Interest Update

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 8,500,000 shares, a growth of 20.9% from the November 30th total of 7,030,000 shares. Currently, 23.7% of the company’s shares are short sold. Based on an […]
Johnr Moore Jonathanc Fox Blackrock Inc Vanguard Group Inc Metlife Investment Management Edgewise Therapeutics Inc

John R. Moore Sells 1,897 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Stock

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Rating) General Counsel John R. Moore sold 1,897 shares of Edgewise Therapeutics stock in a transaction dated Tuesday, May 2nd. The stock was sold at an average price of $8.90, for a total value of $16,883.30. Following the sale, the general counsel now owns 6,565 shares in the company, […]
Johnr Moore Edgewise Therapeutics Inc Securities Exchange Commission Citadel Advisors Blackrock Inc Vanguard Group Inc

John R. Moore Sells 15,230 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Stock

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Rating) General Counsel John R. Moore sold 15,230 shares of the business’s stock in a transaction on Friday, June 3rd. The shares were sold at an average price of $6.05, for a total transaction of $92,141.50. Following the completion of the sale, the general counsel now directly owns 3,000 […]
Johnr Moore Zacks Investment Research Edgewise Therapeutics Company Profile Get Rating Jpmorgan Chase Co Dynamic Technology Lab Private Ltd Goldman Sachs Group

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) General Counsel Sells $80,136.00 in Stock

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Rating) General Counsel John R. Moore sold 10,800 shares of the firm’s stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $7.42, for a total transaction of $80,136.00. Following the completion of the transaction, the general counsel now directly owns 3,000 […]
Nova Scotia United States Johnr Moore American Century Companies Inc Zacks Investment Research Blackrock Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science